Jun. 15, 2025
A new preclinical study has demonstrated that cochlear gene therapy can restore both hearing and auditory processing in a mouse model of atypical DFNB9 deafness, a genetic condition caused by mutations in the OTOF gene. The findings, published in Communications Medicine, offer promising insights for treating a broader range of hearing loss severities associated with this condition—not just those involving
















